NASDAQ:RARE Shareholder Notice: Investigation over Potential Wrongdoing at Ultragenyx Pharmaceutical Inc.
Certain directors of Ultragenyx Pharmaceutical Inc. are under investigation over potential breaches of fiduciary duties.
View full press release